What to Do When a Dividend Aristocrat Trips
It’s risky to predict when a long winning streak will end, but that outcome isn’t rare.
By Lou Carlozo, Contributor June 11, 2019, at 1:22 p.m.
In financial parlance that befits a royal family, Johnson & Johnson (ticker: JNJ) is known in financial parlance as a “dividend aristocrat.” For 56 years now – ever since John F. Kennedy was in the White House – the health care and pharmaceutical giant has increased payouts every consecutive year.
The latest quarterly disbursement stands at 95 cents per share. That’s already up a nickel from the previous payout and double what it was in 2009. Nothing has been able to stop the dividend growth, not even the Great Recession that shipwrecked many a juggernaut company, such as Citigroup.